AngioDynamics Inc. (ANGO) Tops Q3 EPS by 3c, Provides FY11 Guidance
AngioDynamics Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.03 better than the analyst estimate of $0.12. Revenue for the quarter came in at $54.6 million versus the consensus estimate of $53.89 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.
AngioDynamics Inc. sees FY2011 EPS of $0.48-$0.50, versus the consensus of $0.49. AngioDynamics Inc. sees FY2011 revenue of $217-$220 million, versus the consensus of $220.2 million.